Also Read: The Danish company filed the lawsuit in US District Court in New Jersey, alleging Lilly violated federal and state false advertising and unfair competition laws, including the Lanham Act, through nationwide advertising campaigns for obesity drug Zepbound and diabetes treatment Mounjaro
Adjustments or timing changes might be recommended
Get the nutrients your body needs right away
Jastreboff et al., NEJM, 2022 (SURMOUNT-1) The Next Generation of Metabolic Medicine The efficacy and safety of Tirzepatide are supported by the extensive SURPASS and SURMOUNT clinical trial programs, heralding a new era in weight management
But here's what I tell my patients when they're on GLP-1 medications: you still have to eat enough protein and fiber
Introduction Dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide 1 (GLP-1) receptor agonist